Is there a gender gap in secondary prevention of coronary artery disease in Turkey?
| Autor: | Kocyigit, Duygu, Tokgozoglu, Lale, Kayikcioglu, Meral, Altay, Servet, Aydogdu, Sinan, Barcin, Cem, Bostan, Cem, Cakmak, Huseyin Altug, Catakoglu, Alp Burak, Emet, Samim, Ergene, Oktay, Kalkan, Ali Kemal, Kaya, Baris, Kaya, Cansin, Kaymaz, Cihangir, Koylan, Nevrez, Kultursay, Hakan, Oguz, Aytekin, Ozpelit, Ebru, Unlu, Serkan |
|---|---|
| Přispěvatelé: | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Catakoglu, Alp Burak, Ege Üniversitesi |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
cardiovascular risk factors lcsh:Internal medicine lcsh:Diseases of the circulatory (Cardiovascular) system Turkey lcsh:R Gender lcsh:Medicine Coronary Artery Disease Middle Aged coronary artery disease gender secondary prevention Cross-Sectional Studies Sex Factors lcsh:RC666-701 Secondary Prevention Humans Female lcsh:RC31-1245 Aged |
| Zdroj: | Türk Kardiyoloji Derneği Arşivi, Vol 46, Iss 8, Pp 683-691 (2018) |
| ISSN: | 1016-5169 |
| Popis: | WOS: 000453086300006 PubMed ID: 30516526 Objective: It has been reported that women receive fewer preventive recommendations regarding pharmacological treatment, lifestyle modifications, and cardiac rehabilitation compared with men who have a similar risk profile. This study was an investigation of the impact of gender on cardiovascular risk profile and secondary prevention measures for coronary artery disease (CAD) in the Turkish population. Methods: Statistical analyses were based on the European Action on Secondary and Primary Prevention through Intervention to Reduce Events (EUROASPIRE)-IV cross-sectional survey data obtained from 17 centers in Turkey. Male and female patients, aged 18 to 80 years, who were hospitalized for a first or recurrent coronary event (coronary artery bypass graft, percutaneous coronary intervention, acute myocardial infarction, or acute myocardial ischemia) were eligible. Results: A total of 88 (19.7%) females and 358 males (80.3%) were included. At the time of the index event, the females were significantly older (p=0.003) and had received less formal education (p0.05). Conclusion: Achievement of ideal body weight, fasting blood glucose and blood pressure targets was lower in women despite similar reported medication use. This highlights the importance of the implementation of lifestyle measures and adherence to medications in women. AstraZeneca BioPharmaceutical Company, Istanbul, Turkey The EUROASPIRE-IV Turkey study was unconditionally supported by AstraZeneca BioPharmaceutical Company, Istanbul, Turkey. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|